chr2-151436830-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018151.5(RIF1):c.1199C>A(p.Ala400Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,550,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018151.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIF1 | NM_018151.5 | c.1199C>A | p.Ala400Asp | missense_variant | 12/36 | ENST00000444746.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIF1 | ENST00000444746.7 | c.1199C>A | p.Ala400Asp | missense_variant | 12/36 | 1 | NM_018151.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000665 AC: 1AN: 150320Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000470 AC: 1AN: 212886Hom.: 0 AF XY: 0.00000862 AC XY: 1AN XY: 116002
GnomAD4 exome AF: 0.0000150 AC: 21AN: 1400254Hom.: 0 Cov.: 33 AF XY: 0.0000173 AC XY: 12AN XY: 694380
GnomAD4 genome AF: 0.00000665 AC: 1AN: 150320Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 73184
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 04, 2023 | The c.1199C>A (p.A400D) alteration is located in exon 12 (coding exon 11) of the RIF1 gene. This alteration results from a C to A substitution at nucleotide position 1199, causing the alanine (A) at amino acid position 400 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at